Kocoglu MH, Richardson PG, Mo CC, Rapoport AP, Atanackovic D. Defibrotide improves COVID-19-related acute respiratory distress syndrome in myeloma patients after chimeric antigen receptor T-cell treatment without compromising virus-specific and anti-myeloma T-cell responses. haematol [Internet]. 2024Jul.1 [cited 2024Jul.3];109(7):2372-7. Available from: https://haematologica.org/article/view/haematol.2023.284793